Photothermal cancer therapy is an alternative to chemotherapy, radiotherapy, and surgery. With the development of nanophotothermal agents, this therapy holds immense potential in clinical translation. However, the toxicity issues derived from the fact that nanomaterials are trapped and retained in the reticuloendothelial systems limit their biomedical application. Developing biodegradable photothermal agents is the most practical route to address these concerns. In addition to the physicochemical properties of nanomaterials, various internal and external stimuli play key roles on nanomaterials uptake, transport, and clearance. In this review, we summarized novel nanoplatforms for photothermal therapy; these nanoplatforms can elicit stimuli-triggered degradation. We focused on the recent innovative designs endowed with biodegradable photothermal agents under different stimuli, including enzyme, pH, and near-infrared (NIR) laser.
Introduction
Photothermal therapy (PTT), which employs photothermal agents (PTAs) to convert light to heat for the thermal ablation of cancer cells, has attracted great attention because of certain advantages, such as minimal invasiveness, high specificity, few complications, and low toxicity to normal tissues 1 . Studies have been devoted in the exploration of numerous nano-PTAs for PTT, including gold-based nanostructures [2] [3] [4] , conjugated polymers 5, 6 , carbon nanomaterials (NMs) 7, 8 , semiconductor NMs 9, 10 , and other currently developed nano-PTAs 11, 12 . Although most of them exhibit high therapeutic efficacy, clinical translation has been restricted because of certain concerns with regard to their long-term accumulation in the main organs, which could result in toxicity 13 , side effects 14 , and inflammatory response 15 . Our recent study evaluated the biodistribution and clearance of gold nanoshells during which polyethylene glycol (PEG)-functionalized gold nanoshells were mostly retained in the liver and spleen, even at 15 days after injection 16 . The slow clearance from these organs was consistent with the low excretion of Au content from urine and feces samples 17 . According to the US Food and Drug Administration (FDA), theranostic agents in clinics must be eliminated or cleared in a reasonable period of time 18 . Therefore, biodegradability and biocompatibility have become essential requirements for the clinical applications of PTAs.
Novel nanoplatforms that can elicit stimuli-responsive degradation show great promise in nanoscience and nanomedicine. Biodegradable polymers are preferable because of their good biocompatibility, identified degradation mechanism, and set of metabolic pathways. Conventional methods for the preparation of stimuliresponsive polymers involve the incorporation of cleavable linkages into the main chains 19 or pendant chains 20 . Their long molecular chains are first ruptured by biological activity 21 . Then the fragmented carbon chains are metabolized by different organisms. In contrast to the organic NMs, inorganic nanoparticles have limited clinical translations because of the concerns regarding their longterm toxicity. A recent review introduced certain biodegradable inorganic materials investigated in preclinical studies 22 . Iron oxide nanoparticles (IONPs) have been found to release a trace element of Fe ions to the bloodstream during certain metabolic processes 23 . Porous silicon nanoparticles are degraded into water-soluble silicic acid and then are eliminated from the body in 1 week 24 . As NMs smaller than 5.5 nm can achieve renal clearance 25 , inorganic NMs with smaller sizes are likely degraded into nontoxic products and eliminated through the kidneys 24 .
In view of the expanding research on PTAs, the most recent and relevant reviews have focused on the synthesis and applications of PTAs 26 . However, the processes in the biodegradation of PTAs require further research. In this review, we focused on the different types of stimuli, including those in the internal environment (enzymes, pH, and temperature) and in the external environment (light irradiation, magnetic field, and ultrasound), which are exploited to initiate the degradation of PTAs. Along with the innovative design or structure that can be subjected to biodegradation under these stimuli, the photothermal efficiency and degradation behavior were addressed. The major targeting delivery and clearance pathway of the biodegradable PTAs were discussed. Finally, we recapitulated these biodegradable PTAs and the challenges in PTT with regard to clinical application of the former.
Stimuli-responsive degradation
Stimuli-responsive degradation of PTAs can decrease the accumulation and retention of PTAs in vivo through effective clearance. They undergo hydrolytic cleavage, surface oxidation, or structural fracture in response to a certain stimulus. In this section, we discuss certain of biodegradable PTAs that take advantage of various stimuli, such as enzyme, pH, and near-infrared (NIR) laser.
Enzyme-induced degradation

Enzyme-catalyzed hydrolysis degradation
Phospholipase A2 (PLA2) is a well-known hydrolysis agent used for recognizing and hydrolyzing the sn-2 acyl bond of phospholipids that releases free fatty acids and lysophosphatidic acid 27 . These enzymes are commonly found in mammalian tissues and are overexpressed in tumors. This unique characteristic of PLA2 can enable the use of biodegradable lipid-based structures in biomedical applications. For example, liposomes with lipid bilayers have been approved as drug carriers because of their biodegradability 28 . In this regard,many efforts have been made to improve their NIR absorption. Several methods to improve their NIR absorption were thus discovered, such as the loading of indocyanine green (ICG) in aqueous core 29 or lipid bilayer of liposome 30 .
In 2011, Lovell et al. 31 developed a novel liposome-like structure (porphysomes) by self-assembled porphyrin analogue-lipid conjugation (1:1 molecule ratio). The porphyrin analogue (pyropheophorbide or bacteriochlorophyll) was located at the sn-2 position of the lysophosphatidylcholine ( Figure 1A) . Alternatively, metal ions can be inserted into the porphyrin-lipid structure to form unique metal-chelating bilayers. These liposome-like porphysomes containing approximately 80,000 porphyrins can effectively convert light into heat through the fluorescence-quenching porphyrins in the intact porphysomes. This high conversion efficiency is comparable with gold nanorods under 673 nm laser irradiation ( Figure  1B ). When exposed to laser (658 nm, 1.9 W/cm 2 ), the injected pyropheophorbide-porphysomes (42 mg/kg) can lead to a temperature increase (up to 60 °C), which can completely eradicate KB tumors in xenograft-bearing mice ( Figure 1C) . Jin et al. 32 corroborated the toxicity of the photothermal effect in tumors but not the photodynamic effect. They also found that the heat generated by the porphysomes is highly dependent on their integrated structure, and the singlet oxygen production can restore on the disrupting structure. For biodegradability, pyropheophorbide-porphysomes could degrade into the starting material when incubated with lipase, as shown in Figure 1A . The nature of the enzymatic biodegradation in vitro was likely because of the cleaving of the porphyrin by lipase in the sn-2 position of lipid 33 . Lovell et al. 33 further confirmed the substantial degradation of pyropheophorbideporphysomes after in vivo intravenous (IV) administration. Moreover, no toxicity was observed after the introduction of pyropheophorbide-porphysomes (1,000 mg/kg) in the system, thus it is highly biocompatible.
Liposome-gold clusters are another lipid-based structures formed through the assembling of gold clusters on the liposome core 34 . The high-density packing of gold clusters retains the NIR absorption property of the metallic shells, and the liposome scaffold provides degradability. According to the literature, the destabilization of the liposome template facilitates the splitting of gold nanoparticles into small particles with a renal clearance size (5-6 nm) (Figure 2A) . When the liposome-gold clusters suspension was incubated with PLA2 and Ca 2+ at 45 °C overnight, the plasmon resonance gradually disappeared and changed its color. As for the Triton X-100, the remaining suspension showed an average diameter of ~5.7 nm, indicating the degradation of the composite. Troutman et al. 34 first reported the architecture of the liposome-gold clusters based on a dialkyl phosphatidylcholine (DPPC) template. Rengan et al. 35 investigated the antitumor effects of liposome-gold clusters on MCF-7 cancer cell and performed a pharmacokinetic study on liposome-gold clusters using mice. For PTT, 15 μg/mL liposome-gold clusters can efficiently ablate cancer cells, which is indicated by the breaking of the DNA double strands under NIR laser (750 nm, 650 mW) illumination for 4 min ( Figure 2B ). Quantitative analysis on feces and urine samples identified the hepato-biliary and renal pathway clearance of the small particles ( Figure 2C ). Liposome-gold clusters tend to aggregate in the major organs and they gradually cleave into smaller particles after IV injection ( Figure 2D) . Apart from the enzymatic degradation, the NIR light can be used to initiate the destabilization of the liposome-gold clusters for spatial-and temporal-controlled content release 36-38 .
Enzyme-catalyzed oxidation degradation
Horseradish peroxidase (HRP) is among the extensively used metalloenzymes for catalytic oxidation in a variety of substrates, frequently in the presence of hydrogen peroxide (H 2 O 2 ). This oxidation action is known to imitate the redox process in a cellular metabolism. In 2008, researchers discovered that single-walled carbon nanotubes (SWNTs) can be degraded by HRP in the presence of H 2 O 2 . After 12 weeks of incubation in phosphate buffered saline (PBS) at 4 °C, no distinct tubular structure of carbon nanotubes were observed, thereby indicating that nearly all nanotube materials were degraded 39 . To further investigate the mechanism of HRP-catalyzed degradation, Allen et al. 40 compared the degradation course of the carboxylated SWNTs and the pristine SWNTs using HRP and H 2 O 2 . Their data suggested that the hydrophobic surface on pristine SWNTs were resistant to the HRP catalyst, whereas the carboxylated sites on the SWNTs facilitated the adsorption of HRP, thereby enhancing the catalytic effect. Moreover, the degraded products gradually evolved from oxidized aromatic fragments to CO 2 . These results can be extended to the 
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degradation of SWNTs in living systems [41] [42] [43] [44] . When incubated with neutrophils and macrophages, the SWNTs were also degraded by myeloperoxidase. Particularly, the SWNTs first produced defects in the outer wall, and the developed defects initiated structure alterations over increased incubation time 41 . Moreover, the experiments on mice proved in vivo that the oxidative biodegradation of SWNTs is associated to human myeloperoxidase 42 . Some researchers also reported that SWNTs can be degraded in the brain cortex 45 and in the primary microglial culture models 46 . They emphasized that the defects or the functionalized sites on carbon nanotubes significantly facilitate enzymatic action. HRP-induced degradation of multiwalled carbon nanotubes with defective sites in the graphitic walls was demonstrated by Zhao et al. 47 . Carbon nanotubes cancer mediate photothermal tumor destruction which has been documented in several studies [48] [49] [50] [51] [52] [53] , but their slow degradation rate in vivo and their degradation byproduct such as reactive oxygen species 43, 44 are still unsuitable for clinical application. The structural design and surface functionalization that exposed more active sites (carboxylic groups, defects) on the graphitic surface could accelerate this enzymatic degradation.
Graphene oxide (GO) is another graphite derivative that have shown great potential for biological applications in photothermal therapy and drug delivery. The development of biodegradable GOs is of great importance, and can promote the development of nanomedicine. As GOs have similar sp 2 allotropes of carbon similar to carbon nanotubes, they were also reported to be able to undergo similar HRP-induced oxidative degradation in the presence of H 2 O 2 54 . Figure 3A shows the molecular modeling of an HRP on a GO. Because of the effect of the HRP, the basal plane of the GO gradually produced certain holes, which can act as cleavage sites for carbon-carbon bonds. This result is consistent with the observations in the transmission electron microscopy (TEM) images ( Figure 3B ) and atomic force microscopy (AFM) images ( Figure 3C ). Afterward,a gradual tendency of graphene to disorganize its structure in vivo was observed at the 3rd month after injection. This process was related to the processes of the tissue-bound macrophages. However, the problems of long-term retention still cannot be addressed, which lead to toxicity risks and immune response 55 . To improve its biocompatibility, GO is usually functionalized with PEG or bovine serum albumin (BSA), producing PEG-GO and BSA-GO. However, PEG-GO and BSA-GO cannot degrade in HRP and H 2 O 2 because the PEG or BSA in the GO surface inhibits the interaction between the HRP and GO 56 . When GO was functionalized with a cleavable PEG (mPEG-SS-NH 2 ), the generated GO-SS-PEG cleaved the disulfide linkages by dithiothreitol, resulting in the degradation in HRP and H 2 O 2 56 . Similarly, the GO-SS-PEG degradation in A549 cells can be triggered by a high concentration of glutathione 57 .
pH-induced degradation
The interstitial pH of tumor tissues is ~6.8, which is lower than that of the normal tissues (pH=7.2-7.4). Moreover the endosomes and lysosomes show lower pH levels (pH<6.0) 58 . This difference in pH can be utilized for degrading the main structure of NMs.
pH-induced hydrolysis degradation
In the previous years, a great number of biodegradable polymer-like poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(ε-caprolactone) (PCL), and poly(lactic-coglycolic) (PLGA) were approved by the FDA for in vivo application 59 . These acid-labile groups, similar to ester and anhydride, can be introduced in polymeric matrices to modify the chain degradation. Under acidic environment, these groups can undergo hydrolysis of their ester bonds, and the remaining moieties can be metabolized by the normal acid cycle. Because these biodegradable polymers generally cannot intrinsically absorb light in the NIR region, some researchers have devoted extensive efforts to integrate these polymers to PTAs in order to enhance absorption in the NIR region. Zheng et al. 60 developed a single-step sonication method to entrap the ICG within the PLGA-lipid NPs for in vivo tumor-targeting imaging. They then expanded the PLGA-lipid NPs to incorporate doxorubicin (DOX) and ICG simultaneously for combined chemo-photothermal therapy 61 . They noted that the fluorescence of ICG-PLGAlipid NPs could facilitate the visualization of in vivo metabolic distribution 62 .
In another work, Tam et al. 63 and Murthy et al. 64 produced a certain type of biodegradable plasmonic nanoclusters through linking several ~4 nm gold particles (AuNPs) using degradable polymers. This degradable linkers are triblock copolymers, also known as PLA(2K)-b-PEG(10K)-b-PLA(2K), which can be degraded under low pH level to release the primary AuNPs (Figure 4A) . Specifically, lysine/citrate-capped AuNPs mixed with PLA(2K)-b-PEG(10K)-b-PLA(2K) gradually coagulated and aggregated, thus forming a considerably large cluster during solvent evaporation ( Figure 4B) . Their corresponding localized surface plasma resonance (LSPR) spectra showed a red shift as the interparticle spaces between the AuNPs decreased. This approach facilitated the control of the nanocluster size and the optical properties by turning particle volume fractions 65 . The resulted nanocluster reverted into the original ~4 nm at pH 5, and the associated extinction spectra also reverted to the constituent ligand-capped AuNPs. Similar results were observed in macrophage cells. Particularly, small particles less than 5 nm in diameter appeared in the cells after 168 h (Figure 4C ). This degradable nanocluster showed enormous potential for PTT, and was later applied in photoacoustic imaging 66 .
pH-induced oxidization degradation
pH-dependent oxidization degradation was recently found in some inorganic NMs that underwent low-valence stateoxidized state transition. In 2016, Song et al. 67 found MoOx-PEG has a unique pH-dependent degradation process because it can retain its stability in an acidic environment, and quickly degrades at physiological pH. X-ray photoelectron spectroscopy (XPS) showed that most of the Mo V in the initial MoOx-PEG was oxidized into Mo VI after incubation in PBS (pH=7.4) for 24 h. Based on their LSPR absorption measurements, and their obtained small-angle Xray diffraction and TEM images, they proposed that MoOx-PEG suffered oxidization degradation. The in vivo degradation behaviors observed in Liu's study supported this result. After IV injection of MoOx-PEG (20 mg/kg), it took 7 days to finish the clearance in both the renal and fecal pathways. When exposed to laser light (808 nm, 0.7 W/cm 2 ), the IV injected MoOx-PEG efficiently ablated the tumors without recurrence within 16 days. Song et al. 67 considered that MoOx-PEG suffered gradual oxidation resulting in production of [Mo VI O 4 ] 2-ions or ultra-small NPs, which facilitate renal clearance. Interestingly, MoOx-PEG removal process did not cause toxicity both in vitro and in vivo.
Another example of pH-dependent oxidization degradation was found in the ultrasmall Cu 3 BiS 3 nanodots (NDs) which were developed by the group of Chen ( Figure  5A ) 68 These synthetic Cu 3 BiS 3 NDs had a diameter of 10 nm and were almost cleared through renal filtration and urinary excretion at the 24th hour post-injection ( Figure 5C ). In addition to renal clearance of Cu 3 BiS 3 NDs, Liu et al. 68 proposed that the Cu 3 BiS 3 NDs can undergo oxidation and transformation in the artificial lysosomal fluid (ALF). Synchrotron radiation-based X-ray absorption near-edge structure showed that the Cu 3 BiS 3 NDs transformed into 90.8% oxidized species after incubation in the ALF (pH=4.5) for 24 h (Figure 5D ). This rapid and thorough degradation and clearance process greatly reduced the potential toxicity. Histological examination and blood biochemistry showed that Cu 3 BiS 3 at a certain dose did not cause toxicity in vivo.
NIR laser-induced degradation
Laser irradiation is the basic condition in PTT and it may cause structural damage that accelerates the metabolism of NMs. As discussed in the previous section, the degradation of the developed biodegradable plasmonic nanoclusters by Yoon et al. 69 was laser-fluence-dependent. When laser fluence exceeded 8 mJ/cm 2 , 130 nm nanoclusters showed certain changes in the absorbance spectra. This change was more evident when laser fluence exceeded 20 mJ/cm 2 . Yoon et al. 69 owed this spectral change to the morphological change. This characteristic is to the reshaping of gold nanorods after laser irradiation 70 . This light stability was also highly dependent on material composition and binding forces. For liposome-gold clusters, Rengan et al. 36 found that 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) based liposome-gold clusters disassembled into small gold particles of ~5 nm after 20 min of laser irradiation (750 nm, 650 mW). Furthermore, 7.5 min of laser irradiation (750 nm, 650 mW) was sufficient for killing the MDA-MB-231 cells. In another study, NIR light excitation (2.0 W/cm 2 , 40 s) triggered the disintegration of the hollow copper sulfide nanoparticles (HCuSNPs) into small CuS NPs (7-12 nm) because of the polycrystalline CuS of the shells. This laser-triggered disintegration of HCuSNPs accelerated their elimination from the tumors. Quantitative analysis showed approximately 21% ID of Cu was removed from the tumors while it was increased to ~47% ID under laser treatment within 14 days. Owing to this unique feature, a NIR lighttransformable nanocomposite was constructed by assembling cytosine-guanine (CpG) on chitosan-coated HCuSNPs. The nanocomposite was then used for photothermal and immune combined cancer therapy 71 .
Recently, the self-assembly of the amphiphilic block copolymer-tethered AuNPs provide a versatile approach to develop novel biodegradable polymer/AuNPs assemblies for PTT 72 . When amphiphilic block copolymers show structural damage or change in vivo, the building blocks dissociate into their original sizes, thereby facilitating their elimination from the body. The main assemblage methods are the film rehydration method and the selective solvent method that closely packs AuNPs, which turn LSPR peaks in the NIR region 73, 74 . In 2015, Deng et al. 75 applied this method to produce biocompatible gold nanomicelles based on amphipathic polymer (p-(MEO 2 MA-co-(HEMA-gPCL))-tethered AuNPs. The amphipathic polymer was terminated with the mercapto groups, thereby forming a comb shape, which could pack more AuNPs and could generate ultrastrong plasmonic coupling. When exposed to NIR laser (808 nm, 1.5 W/cm 2 ) for 5 min, 0.2 mg/mL of the gold nanomicelle solution can be heated to 57 °C. After NIR laser irradiation, each nanomicelle dissociate into a small size of 6 nm, as proven by the TEM images. This phenomenon was later demonstrated in vivo. The nanomicelles showed no observable toxicity even at high incubation concentrations, but the dissociated AuNPs were not rapidly eliminated through renal activity 75 .
Degradation induced by other factors
In addition to the above-defined stimulus, some PTAs with degradation mechanisms that are still unknown or not proven are reviewed in this section. For example, systemically administered IONPs are first absorbed by the mononuclear phagocytic system of the liver and the spleen and then degraded into Fe ions by lysosomes. The degraded irons are then retained in storage proteins or are eliminated from the body through the typical iron metabolic pathways [76] [77] [78] . Currently, IONPs are extensively applied in biomedicine, particularly in magnetic resonance imaging (MRI), drug delivery, and hyperthermia treatment 79 .
Chen et al. 80 reported that a certain type of highly crystallized IONPs (HCIONPs) coated with a polysiloxanecontaining diblock copolymer is an effective and biodegradable mediator for PTT. These HCIONPs synthesized by thermal decomposition with certain modifications have a desirable plane orientation that can induce photothermal effect. When exposed to NIR irradiation (885 nm, 2.5 W/cm 2 ), the HCIONP solution (0.5 mg/mL, Fe) produced a considerably higher temperature (33 °C) than pure water (3 °C). In vivo tumor photothermal therapy was further examined through intravenously administered HCIONPs, and the SUM-159 tumor completely regressed under the same laser irradiation parameters. Moreover, the copolymer coating did not change the biodegradability of the IONPs, as indicated by the inductively coupled plasma mass spectrometry (ICP-MS), which showed the absence of significant difference in the iron concentrations of the organs between the HCIONPs-treated mice and the controlled, mice after photothermal therapy. The hematoxylin-and eosin-stained main organs also suggested that the injected HCIONPs did not cause evident tissue damage in mice 80 .
Iron-oxide nanoparticles can integrate with PTAs to improve their photothermal efficiency for PTT. Ma et al. 81 developed a biodegradable nanocomposite based on 1,2-distearoylsn-glycero-3-phosphoethanolamine-N-methoxy (polyethylene glycol) (DSPE-PEG) coated superparamagnetic iron oxide (SPIO) nanoparticles encapsulating ICG molecules (SPIO@DSPE-PEG/ICG NPs). The resulting SPIO@DSPE-PEG/ICG NPs can maintain the biodegradability of the IONPs and possess high photothermal conversion efficiency. Under NIR laser irradiation, the SPIO@DSPE-PEG/ICG can induce intense temperature elevation, which can be observed in in vitro and in vivo photothermal therapy 81 . Recently, IONPs enveloped by conjugated polymers have been reported to improve photothermal efficiency 82, 83 . Although these nanostructures have been applied successfully in PTT, and have exhibited low toxicity in vitro and in vivo, information on their biodegradability, metabolic pathway, and long-term toxicology is limited 84 .
CuS NPs are recognized as alternatives to gold nanostructures in PTT because of their low toxicity and strong NIR absorption 85, 86 . Copper is an essential element in human health, and excess copper in the body is mainly excreted through bile to maintain balance 87 . As physicochemical properties affect NMs uptake, transport, and fate in vivo, CuS can be metabolized in humans through smart manipulation of their physicochemical properties. In 2013, Guo et al. 88 reported a biodegradable hollow CuS nanoparticle that can be eliminated through hepatobiliary and renal excretion. They proposed the systemically injected PEGylated HCuSNPs accumulated in major organs in which the HCuSNPs split into small CuSNPs and dissociated Cu ions. The hepatobiliary elimination and renal excretion of Cu ions accounted for the 67% ID and the 23 % ID, respectively, within the 1st month of post-injection. After demonstrating the biodegradability of HCuSNPs, they further examined the cytotoxicity of PEG-HCuSNPs. Their results showed that PEG-HCuSNPs had low toxicity at a concentration of 100 μg/mL on RAW 264.7 cells, and the results could be related to the released Cu ions from the CuS 88 .
Targeting delivery of biodegradable PTAs
The newly developed biodegradable PTAs are usually delivered to cancer tissues through passive targeting, which is driven by the enhanced permeability and retention (EPR) effect 89 . As the blood vessels of the tumors are abnormal hyperplasias 90 , with wider space in their vascular walls 91 and with incomplete structures, biodegradable PTAs in the bloodstream can extravasate from leaky vessels into the tumor interstitium. To strengthen the EPR effect, the size of the biodegradable PTAs should be maintained within the range of 60 nm to 400 nm 92 , and the surface of the biodegradable PTAs generally function with PEG to create a hydrophilic protective layer and prolong the blood circulation time. For example, PEG modification increases the blood circulation half-life of Doxil from 30 min to 80 h. Moreover, small NPs show higher tumor penetration efficiency than large NPs 93 , but they can be cleared away from the tumor through the lymphatic drainage 94 .
Ligand-mediated active targeting provides another way to increase the accuracy of the targeting PTAs, which mainly takes advantage of targeting specific antigens or receptors on the surface of tumor cells, in the cancer tissues 95 . Generally, PTAs are conjugated with the corresponding ligands, such as proteins, peptides, aptamers, and small molecules through physical and chemical binding. Our study demonstrated that the uptake of transferrin-conjugated gold nanoshells in MCF-7 cells was 15-fold higher than that of the nonconjugated gold nanoshells 17 . Moreover, PTAs with magnetic properties can deliver to the tumor tissue under the guidance of external magnetic field 96 .
In addition, the cellular internalization of the PTAs is critical in the enhancement of tumor-targeted delivery 97 . Thus, considerable attention is necessary for improvement of the cellular internalization of PTAs through the optimization of their physicochemical properties. For example, NP size can affect the efficiency and the pathway of the cellular uptake 98 . Zhao et al. 62 reported that the cell uptake of ICG-loaded polymer-lipid NPs varied with size, and the NPs with 39 nm size were the most absorbed by tumor cells among the 39 nm, 68 nm, and 116 nm NPs observed. Moreover, NPs with diameters of <200 nm were internalized into cells through clathrin-coated pits. When the size of the NP increases, caveolae-mediated internalization is apparent, and turned into the predominant pathway where 500 nm NPs enter 99 .
Clearance of biodegradable PTAs
Biodegradation of PTAs undergoes a two-step process: degradation and clearance. The clearance pathway of the biodegradable PTAs mainly includes the hepatic clearance and the renal clearance, which are primarily determined by particle size. NMs larger than 10 nm are immediately trapped by reticuloendothelial systems (RES) of the liver and spleen 100 . NMs smaller than 5.5 nm are immediately filtered from the blood by the kidney 25 .
Hepatic clearance of biodegradable PTAs
As the systemically administered PTAs are mostly aggregated and retained in the liver, the hepatic clearance of PTAs is the main metabolic pathway and also related to PTAs' size. PTAs with size less than ~200 nm tend to be cleaned by hepatocytes or to enter the lymphatic circulation, whereas PTAs with size large than ~200 nm are effectively absorbed by the Kupffer cells 101 . The exact clearance mechanism is dependent on the interactions between the PTAs and the intracellular components. Lysosome-mediated degradation, which is the dominant pathway of clearance for the PTAs in the Kupffer cells, is associated with the acid hydrolase enzymes and the acidic microenvironment. For example, lysosomal metabolism of IONPs is relevant to lysosomal α-glucosidase 102 , low pH, and chelates 103 . The hepatic biodegradation capacity is notably limited and excessive accumulation of biodegradable PTAs can cause cytotoxicity.
Renal clearance of biodegradable PTAs
For the inert PTAs that cannot be easily metabolized by the liver, developing cleavable or decomposable PTAs for renal clearance is an effective strategy. Renal clearance first involves glomerular filtration that directly affects renal clearance capability. As the filtration-size threshold is ~5.5 nm 25 , NPs smaller than 5.5 nm can be effectively excreted in the urine. NPs larger than 5.5 nm likely shift to the liver. Deng et al. 75 developed a type of cleavable gold clusters that can decompose into small gold particles (~6 nm). These decomposed AuNPs can be subsequently eliminated through the renal pathway. Quantitative analysis of urine indicated that a 4% dose of elemental Au was cleared on day 7. However, Park et al. 104, 105 found that the PLGA-gold nanoshells were not excreted effectively through the kidneys because the remaining AuNPs retained large sizes. Certain ultrasmall NPs (<10 nm) are among example of renal clearable inorganic NPs 106, 107 . In contrast to biodegradable PTAs, ultrasmall PTAs were rapidly eliminated by the kidneys without undergoing the degradation process. This may weaken the EPR-mediated delivery of PTAs to the cancer cells, thus it could influence the treatment effect of PTT.
Conclusions
Biodegradability has been demonstrated as the key avenue regarding the issue on safety of NMs. In this review, different stimuli-responsive PTAs are presented, and their considered design, degradation behavior, and excretion pathway are discussed. However, limitations and challenges with regard to PTAs still exist.
Current evaluation methods for biocompatibility are mostly focused on acute toxicity. However, long-term toxicity and aberrant cellular responses without toxicity necessitate further evaluation. The aberrant cellular responses include the oxidative stress, DNA damage, abnormal enzyme activity, mitochondrial membrane dysfunction, and changes in gene expression 13 . Furthermore, the consistent criteria and decision method have not been established for biodegradability in vivo. Further understanding on the detailed biodegradation mechanisms, metabolic pathway, and toxicity assessment of inorganic NMs are still progressing. Developing biodegradable PTAs are preferentially based on safe and extensively studied biodegradable materials, such as liposome, polyester, and natural macromolecule.
At present, injected PTAs are mostly dependent on the passive target in the tumor via EPR. Unpredictable degradation of NMs can happen during blood circulation. Therefore, the ideal PTAs should be bioinert and stable in biological environment and can be immediately excreted after carrying out their function. Furthermore, enhanced tumor retention, penetration, cellular internalization, and nuclear uptake of PTAs should be considered. Combination of multi-mode targeting and stimuli-responsive PTAs is a promising direction to attain controllable degradation rates. With the development of programmed biodegradable PTAs, we believe that PTT can be soon translated to clinical applications.
